Cargando…

Companion Diagnostics: State of the Art and New Regulations

Companion diagnostics (CDx) hail promise of improving the drug development process and precision medicine. However, there are various challenges involved in the clinical development and regulation of CDx, which are considered high-risk in vitro diagnostic medical devices given the role they play in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valla, Vasiliki, Alzabin, Saba, Koukoura, Angeliki, Lewis, Amy, Nielsen, Anne Ahlmann, Vassiliadis, Efstathios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512279/ https://www.ncbi.nlm.nih.gov/pubmed/34658618 http://dx.doi.org/10.1177/11772719211047763

Ejemplares similares

Impact of Design on Medical Device Safety
por: Miclăuş, Teodora, et al.
Publicado: (2019)

Preference Testing in Medical Devices: Current Framework and Regulatory Gaps
por: Lewis, Amy, et al.
Publicado: (2022)

The Oxford companion to art
Publicado: (1970)

The current and future state of companion diagnostics
por: Agarwal, Amit, et al.
Publicado: (2015)

A companion to digital art
por: Paul, Christiane
Publicado: (2016)

Companion diagnostics: changing patient management
Publicado: (2012)

In situ Protein Detection for Companion Diagnostics
por: Gremel, Gabriela, et al.
Publicado: (2013)

Factor VIII companion diagnostic for haemophilia
por: Hu, Chunxiao, et al.
Publicado: (2022)

Cytokine storm during chemotherapy: a new companion diagnostic emerges?
por: Filippou, Panagiota S., et al.
Publicado: (2020)

Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics—Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer
por: Plönes, Till, et al.
Publicado: (2016)

Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan
por: Shimazawa, R, et al.
Publicado: (2014)

Diagnostic Investigation of Emerging Viruses of Companion Animals
por: Kapil, Sanjay, et al.
Publicado: (2008)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

Multiplexed Prostate Cancer Companion Diagnostic Devices
por: Aidoo-Brown, Josephine, et al.
Publicado: (2021)

Companion diagnostics: new opportunities for safe and effective anti-infectious disease therapies
por: Zhou, Yong-Jie, et al.
Publicado: (2018)

Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient Selection
por: Huber, Cynthia, et al.
Publicado: (2021)

A Systematic Database Approach to Identify Companion Diagnostic Testing in Clinical Trials under the New In Vitro Diagnostic Medical Devices Regulation
por: Wollenhaupt, Clara, et al.
Publicado: (2023)

Molecular diagnostics of gliomas: state of the art
por: Riemenschneider, Markus J., et al.
Publicado: (2010)

Follitropin Delta as a State-of-the-Art Incorporated Companion for Assisted Reproductive Procedures: A Two Year Observational Study
por: Doroftei, Bogdan, et al.
Publicado: (2021)

Personalized health care beyond oncology: new indications for immunoassay‐based companion diagnostics
por: Batrla, Richard, et al.
Publicado: (2015)

Aligning the Economic Value of Companion Diagnostics and Stratified Medicines
por: Blair, Edward D., et al.
Publicado: (2012)

Precision Medicine for Rheumatoid Arthritis: The Right Drug for the Right Patient—Companion Diagnostics
por: Meehan, Richard Thomas, et al.
Publicado: (2021)

Companion to baroque music
por: Anne Sadie, july

Hepatocellular carcinoma: State of the art diagnostic imaging
por: Criss, Cody, et al.
Publicado: (2023)

Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects
por: Olsen, Dana, et al.
Publicado: (2014)

Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
por: Jørgensen, Jan Trøst, et al.
Publicado: (2022)

374 Therapeutic Class Labeling of EGFR Companion Diagnostics (CDxs)
por: Chen, Joyce, et al.
Publicado: (2022)

Point-of-care testing in companion and food animal disease diagnostics
por: Velayudhan, Binu T., et al.
Publicado: (2022)

Emerging biomedical imaging-based companion diagnostics for precision medicine
por: Liao, Shiyi, et al.
Publicado: (2023)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Navigating the Rapids: The Development of Regulated Next-Generation Sequencing-Based Clinical Trial Assays and Companion Diagnostics
por: Pant, Saumya, et al.
Publicado: (2014)

The New Third Appendix to Squire's Pocket Companion
Publicado: (1910)

Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance
por: Alzabin, Saba, et al.
Publicado: (2012)

Regulating Companion Dog Welfare: A Comparative Study of Legal Frameworks in Western Countries
por: Andersen, Søren Stig, et al.
Publicado: (2021)

Diagnostic imaging and intervention of the musculoskeletal system: state of the art
por: Barile, Antonio, et al.
Publicado: (2018)

Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials
por: Van Heertum, Ronald L, et al.
Publicado: (2015)

Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives
por: Myers, Meagan B
Publicado: (2016)

Lyme disease: the promise of Big Data, companion diagnostics and precision medicine
por: Stricker, Raphael B, et al.
Publicado: (2016)

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET
por: Huang, Fangjin, et al.
Publicado: (2016)

Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch
por: Scheerens, H, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f1atbf2ndljt2i6pr4pn5s7vgq